- Home
- BJRI vs TNDM Comparison
BJRI vs TNDM Comparison
Compare BJRI & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BJRI
- TNDM
- Stock Information
- Founded
- BJRI 1978
- TNDM 2006
- Country
- BJRI United States
- TNDM United States
- Employees
- BJRI N/A
- TNDM N/A
- Industry
- BJRI Restaurants
- TNDM Medical/Dental Instruments
- Sector
- BJRI Consumer Discretionary
- TNDM Health Care
- Exchange
- BJRI Nasdaq
- TNDM Nasdaq
- Market Cap
- BJRI 983.0M
- TNDM 1.1B
- IPO Year
- BJRI 1996
- TNDM 2013
- Fundamental
- Price
- BJRI $35.43
- TNDM $15.58
- Analyst Decision
- BJRI Hold
- TNDM Buy
- Analyst Count
- BJRI 5
- TNDM 13
- Target Price
- BJRI $41.40
- TNDM $32.15
- AVG Volume (30 Days)
- BJRI 534.6K
- TNDM 1.7M
- Earning Date
- BJRI 07-31-2025
- TNDM 08-06-2025
- Dividend Yield
- BJRI N/A
- TNDM N/A
- EPS Growth
- BJRI N/A
- TNDM N/A
- EPS
- BJRI 0.95
- TNDM N/A
- Revenue
- BJRI $1,367,941,000.00
- TNDM $982,951,000.00
- Revenue This Year
- BJRI $5.58
- TNDM $8.91
- Revenue Next Year
- BJRI $2.93
- TNDM $11.04
- P/E Ratio
- BJRI $38.56
- TNDM N/A
- Revenue Growth
- BJRI 2.91
- TNDM 27.65
- 52 Week Low
- BJRI $27.61
- TNDM $14.31
- 52 Week High
- BJRI $47.02
- TNDM $47.60
- Technical
- Relative Strength Index (RSI)
- BJRI 25.95
- TNDM 41.16
- Support Level
- BJRI $35.99
- TNDM $15.21
- Resistance Level
- BJRI $39.24
- TNDM $17.19
- Average True Range (ATR)
- BJRI 1.31
- TNDM 0.84
- MACD
- BJRI -0.52
- TNDM 0.25
- Stochastic Oscillator
- BJRI 6.24
- TNDM 44.10
About BJRI BJ's Restaurants Inc.
BJ's Restaurants Inc is involved in the business of owning and operating restaurants. The company operates in a single operating segment that is full-service company-owned restaurants. It has geographic presence only in the United States of America.
About TNDM Tandem Diabetes Care Inc.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.